Capecitabine

Capecitabine is an oral fluoropyrimidine prodrug that undergoes stepwise enzymatic conversion to 5-fluorouracil preferentially within tumour tissue, used for colorectal and breast cancer. Simson Pharma's Capecitabine reference standard and impurities support the demanding stability-indicating QC this pro-drug oncology agent requires.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Capecitabine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Capecitabine
Capecitabine
Capecitabine EP Impurity A
Capecitabine EP Impurity B
Capecitabine EP Impurity C
Capecitabine EP Impurity G
Capecitabine EP Impurity F
3`-(5`-Deoxy-alpha-D-ribofuranoyl) Capecitabine
Capecitabine 3-O-BDR Impurity
Capecitabine 2-O-BDR Impurity
Capecitabine EP Impurity D
5`-Deoxy-5-fluoro-N4-(2-methyl-1-butyloxycarbonyl)cytidine + 5`-Deoxy-5-fluoro-N4-(3-methyl-1-butyloxycarbonyl)cytidine
1,2,3-Tri-O-acetyl-5-deoxy-beta-D-ribofuranose
Capecitabine EP Impurity E
tri-O-acetyl-5-deoxy-D-ribofuranose
Capecitabin Impurity M
2`,3`,5`-tri-O-acetyl-5-fluorocytidine
Methyl2,3-O-Isopropylidene-5-O-tosyl-beta-D-ribofuranoside
Capecitabine Impurity 9
alpha-Fluoro-beta-ureidopropionic Acid
isopentyl(1-((2S,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate
Capecitabine Impurity 5
Capecitabine Impurity 4
Capecitabine alpha-Isomer
Capecitabine Impurity 21
Capecitabine Impurity 12
Capecitabine Impurity 14
Capecitabine Impurity 3
Capecitabine Methoxy Analog
Capecitabine Impurity 1
Capecitabine Impurity 2

Isotope Labelled Compounds

Capecitabine-D11